Durham, NC, United States of America

Terrence Lee Smalley, Jr


Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2009-2010

Loading Chart...
4 patents (USPTO):

Title: Spotlight on Inventor Terrence Lee Smalley, Jr.

Introduction: Terrence Lee Smalley, Jr. is a distinguished inventor based in Durham, North Carolina. He holds an impressive portfolio of four patents, showcasing his contributions to therapeutic compounds and innovative pharmaceutical solutions.

Latest Patents: Among his notable patents, two recent inventions stand out. The first is titled "Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40." This patent focuses on novel therapeutic compounds that serve as GPR40 agonists, detailing their manufacture processes and beneficial intermediates. The second patent, "Cycloalkylidene compounds as modulators of estrogen receptor," pertains to unique substituted cyclic alkylidene compounds with diverse therapeutic applications, notably in selective estrogen receptor modulation.

Career Highlights: Terrence has made significant strides during his career, contributing to prominent organizations such as GlaxoSmithKline LLC and SmithKline Beecham Corporation. His work within these companies has marked him as a key innovator in the field of medicinal chemistry.

Collaborations: Throughout his career, Terrence has collaborated with several accomplished colleagues, including Jing Fang and Dennis Heyer. These partnerships have contributed to his success and the advancement of his inventions.

Conclusion: In summary, Terrence Lee Smalley, Jr.'s contributions to the field of pharmaceutical innovation are both impactful and noteworthy. Through his patents and collaborative efforts, he continues to influence the landscape of therapeutic compounds, demonstrating the vital role of inventors in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…